Received Apr 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | LA |
Swelling arm; This non-serious case was reported by a consumer via sales rep and described the occurrence of swelling arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On 13-SEP-2024, the patient received the 1st dose of Shingrix (left deltoid). On 17-SEP-2024, 4 days after receiving Shingrix, the patient experienced swelling arm (Verbatim: Swelling arm). On 24-SEP-2024, the outcome of the swelling arm was resolved. The reporter considered the swelling arm to be related to Shingrix. The company considered the swelling arm to be related to Shingrix. Additional Information: GSK Receipt Date: 03-APR-2025 The patient self reported this case for himself. Patient had swelling greater than 100 mm took 7 to 10 days to resolve.